PPT-Current management of COPD and when to refer?

Dr Maxine Hardinge Consultant Respiratory Medicine Oxford University Hospitals NHS Foundation Trust Aims of treatment reducing risk and reducing symptoms Inhaled therapy new Oxfordshire . Over time the airways of those suffering from COPD become permanently obstructed or blocked and gradually lose their ability to function COPD is a major cause of disability and death in Canada and throughout the world According to a recent study 15 What we will cover: . Malnutrition . and COPD. Oral nutrition supplements. Recommended dietary patterns for people with COPD . Bone Health . Obesity. Micronutrient supplements . Katherine Stern . Dietitian 10/10/2014. During your visits at home by the ICOPD team we will consider what can be done to improve your health and try to prevent more flare ups in the future. This might include advice on dietary changes, quitting smoking and information about COPD. We may also advise that you increase your exercise levels and refer you onto one of our exercise programmes.. COPD is characterized by :. **Chronic airflow obstruction & accelerated . . loss of lung function which is progressive & . NOT. fully reversible.. ** COPD is preventable & treatable but . Some highlights. How the lungs work. 2. What is asthma. Sensitive airways . Inflammation . and swelling. More mucus produced. Airways become narrow. Muscles tighten around airways. Breathing is difficult. management. RIANA SARI. 1. Agenda. Definisi. PPOK GOLD 2017. Etiologi. , . patobiologi. & . Patologi. PPOK. Diagnosis . dan. . penilaian. . awal. Tatalaksana. PPOK GOLD 2017. Peranan. . kombinasi. An Update on Current . M. edications and Treatment . O. ptions. Lori Wilken, PharmD. Clinical Assistant Professor. University of Illinois. College of Pharmacy. 2016 RHA LIVING BETTER TOGETHER COPD CONFERENCE. Oakington. , Cambridge, CB24 3BA. Practice Overview. COPD Patient: COPD QOF diagnosis code. Page 1. Contents. . Patient Demographics. COPD Diagnosis. COPD Health Status. Risk and Exacerbations. Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. : . Asthma, bronchitis, COPD, emphysema, cystic fibrosis, bronchiectasis, pneumoconiosis, sleep apnea. Role of Spirometry. Implementing Changes to the ABCD Grouping in Practice . The Refined ABCD Assessment Tool. Pharmacologic Treatment Algorithms. Instruments to Assess Symptoms . Standardized Tools. COPD Assessment Test. Finlay . Royle. Senior Clinical Commissioning Pharmacist. Lambeth CCG. 1. Medicines Optimisation . Key theme: . Quality. , . Safety . and . Medicines . W. aste. 2. Medicines are the most common therapeutic intervention in healthcare, but their use is often . MA-PF-AI-SG-0006-1. Date of preparation, March 2021. . This is a case study of an actual patient, who . provided verbal informed consent. Case description. Name: HVT. Age: 65 years . Gender: male. History and comorbidities: . What is COPD?. How to treat COPD?. What is the prognosis?. 19.3% of US Adults Smoke – 2010. CDC, NHIS 2010. 2010 Current Smokers. %. of Smokers. Demographic. % of Smokers. Demographic. 19.3%. US Adults. NR601-Primary Care of the Maturing and Aged . Family . Practicum. Purpose. Students will be able to discuss the epidemiology, definition, and risk factors for COPD. Students will be able to apply knowledge related to the assessment and diagnostic criteria for COPD.